相关实验视频

Updated: Jan 17, 2026

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Published on: April 18, 2025

深度学习在MRI上的应用,用于直肠癌的预后预测

Jia-Hong Zhu¹, Yan Gao², Yan-Bo Wu¹

¹Department of Radiology, Shengjing Hospital of China Medical University, Shenyang, China.

European radiology

|January 15, 2026

概括

结合临床数据和深度学习 (DL) 的新组合模型显著改善了直肠癌患者的治疗前风险评估. 这种方法为个性化治疗策略提供了更准确的预后预测.

科学领域:

在瘤学瘤学.
放射学放射学是一门学科.
人工智能的人工智能

背景情况:

结直肠癌的管理需要精确的预后模型,以优化治疗和临床决策.
当前的模型可能无法充分利用先进的成像和计算技术的潜力.

研究的目的:

为直肠癌开发和验证一个结合模型,将临床特征与深度学习 (DL) 整合在一起.
提高治疗前风险评估和预后准确度.

主要方法:

从三家医院的458名直肠癌患者的回顾性数据收集.
利用多实例学习 (MIL) 来整合预治疗MRI切片的深度学习功能.
构建了一个组图,将DL特征和临床病理参数结合起来,使用Harrell的C指数和时间依赖ROC曲线进行验证.

主要成果:

结合了MIL特征和临床数据的组合模型,与单独的临床或MIL模型相比,显示出更高的预测性能.
在培训,验证和外部测试队列中实现了总体生存 (OS) 和无疾病生存 (DFS) 的高C指数值.
组合模型显示了改善的OS预测 (C指数高达0.822) 和DFS预测 (C指数高达0.768).

结论:

综合模型利用临床和深度学习特征之间的协同效应来提高预后性能.
这种方法使得在直肠癌中更准确和个性化的预治疗风险分层成为可能.
该研究强调了将MIL提取的DL特征与临床知识相结合的关键相关性,以改善患者管理.

关键词:

深度学习是一种深度学习.这就是为什么MRI是MRI.预测预后预测预测这是直肠癌.

更多相关视频

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

Application of Deep Learning-Based Medical Image Segmentation via Orbital Computed Tomography

Application of Deep Learning-Based Medical Image Segmentation via Orbital Computed Tomography

Published on: November 30, 2022

相关概念视频

Magnetic Resonance Imaging

Magnetic Resonance Imaging

Magnetic resonance imaging (MRI) is a noninvasive medical imaging technique based on a phenomenon of nuclear physics discovered in the 1930s, in which matter exposed to magnetic fields and radio waves was found to emit radio signals. In 1970, a physician and researcher named Raymond Damadian noticed that malignant (cancerous) tissue gave off different signals than normal body tissue. He applied for a patent for the first MRI scanning device in clinical use by the early 1980s. The early MRI...